Cargando…
Early presentation of clinical hereditary angioedema symptoms in an infant
Autores principales: | Pham, Hoang, Santucci, Stephanie, Yang, William H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304087/ http://dx.doi.org/10.1186/1710-1492-10-S2-A36 |
Ejemplares similares
-
Self-administration of a novel subcutaneous bradykinin b(2) receptor antagonist, icatibant, as an effective treatment option in patients with hereditary angioedema
por: Santucci, Stephanie, et al.
Publicado: (2014) -
Self-administration of intravenous C1 esterase inhibitor (Berinertâ) in patients with Hereditary Angioedema decreases number of days spent in an emergency room
por: Rizk, Caroline, et al.
Publicado: (2011) -
Type-III hereditary angioedema resolved by surgery
por: Fu, Lisa W, et al.
Publicado: (2014) -
Analysis of icatibant for the treatment of laryngeal hereditary angioedema attacks in the FAST-3 study
por: Yang, William, et al.
Publicado: (2014) -
Therapeutic trial in hereditary angioedema type III: Icatibant
por: Garro, Laila Sabino, et al.
Publicado: (2015)